This review explores the use of iPSCs in the treatment and modeling of skeletal muscle diseases.

Using human induced pluripotent stem cell (iPSC) -derived liver organoids (iHOs), this study successfully obtained powerful iHO-Heps hepatocytes by optimizing culture conditions and developing two-dimensional (2D) culture protocols.

In recent years, mesenchymal stromal cells (MSCs) have become a hot topic in RA treatment research due to their unique immunoregulation and tissue repair capabilities.

Studies have found that iMSCs are not as effective as BM-MSCs in promoting angiogenesis, which are more effective in stimulating endothelial cells to form interconnected vascular structures.

Scientists have turned their attention to a magical small laboratory product-organoids.

Compared with traditional MSC, iPSC-MSC not only has better proliferation ability, but also has a lower risk of age-related variability and heterogeneity.

It was confirmed that after receiving iNSCDAP treatment, the transplanted dopaminergic nerve cells survived and released neurotransmitters, repairing neural function.

This study successfully established the BEX system and achieved large-scale expansion of BTSC and its organoids in vitro.